VIR BIOTECHNOLOGY INC

Vir Biotechnology Board Adds Dr. Suzanne Topalian, Who Immediately Buys a Large Equity Stake

Dr. Suzanne Topalian’s fresh RSU and option buy signals strong insider confidence in Vir Biotechnology’s virology pipeline and board strategy.

VIR BIOTECHNOLOGY INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

28/10/2026, 18:50

3 minutes to read

Vir Biotechnology CFO Holds Stock as Investors Await Clinical Results, Expecting Upside

Explore how Vir Biotechnology’s CFO’s neutral “hold” filing signals confidence in upcoming clinical data and market upside, guiding investors and analysts alike.

VIR BIOTECHNOLOGY INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/10/2026, 20:29

3 minutes to read